NCT02979340View on ClinicalTrials.gov

MRI to Characterize and Predict CF Liver Disease in PUSH Cohort

CompletedOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

January 27, 2017

Primary Completion Date

December 27, 2019

Study Completion Date

December 27, 2019

Conditions
Cystic Fibrosis Liver DiseasePancreatic Insufficiency
Interventions
PROCEDURE

MRI

non-invasive assessment of hepatic fibrosis and steatosis

Trial Locations (8)

21217

Johns Hopkins School of Medicine, Baltimore

30322

Children's Healthcare of Atlanta, Atlanta

45229

Cincinnati Children's Hospital Medical, Cincinnati

46202

Riley Hospital for Children, Indianapolis

63110

Washington University School of Medicine, St Louis

77030

Texas Children's Hospital, Houston

80045

Children's Hospital Colorado, Aurora

98105

Seattle Children's Hospital, Seattle

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT02979340 - MRI to Characterize and Predict CF Liver Disease in PUSH Cohort | Biotech Hunter | Biotech Hunter